Actinogen Medical (ASX:ACW) has reached a critical regulatory milestone in its bid to bring a novel Alzheimer’s treatment to market, securing agreement with the US Food and Drug Administration (FDA) on the path forward for its lead therapy, Xanamem (emestedastat). …
Actinogen secures FDA agreement to advance Xanamem for Alzheimer’s disease
September 15, 2025 Australian Biotech
Latest Video
New Stories
-
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News -
Young NZ cancer patients to get funded medicines no matter where they are treated
October 6, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
CSL announces investment for share of Alentis rare kidney and liver candidate
October 6, 2026 - - Latest News -
TGA approves Roche's refillable eye implant for wet macular degeneration
October 5, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.34
October 2, 2026 - - Podcast -
Under the TGA's new rules, the safest story is one without the patient experience
October 2, 2026 - - Latest News